Genenta Science
GNTA
3 hedge funds and large institutions have $332K invested in Genenta Science in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more ownership
Funds ownership: 0.26% → 0.26% (+0%)
36% less capital invested
Capital invested by funds: $517K → $332K (-$185K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$3.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.61K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AU
1
Algebris (UK)
London,
United Kingdom
| $315K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $14K | -$1.61K | -200 | -9% |
|
|
3
Bank of America
Charlotte,
North Carolina
| $3K | +$3.31K | +411 | New |
|
GNTA Hedge Fund Activity: Q1 2022 in Review
3 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q1 2022, worth a combined $332K — down 36% from $517K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GNTA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $3.31K. The largest seller was UBS Group, cutting an estimated $1.61K.
- 3 institutional investors held Genenta Science (GNTA) as of Q1 2022, up from 2 in Q4 2021.
- Funds reported $332K of Genenta Science stock for Q1 2022, down 36% quarter-over-quarter.
- 1 fund opened new Genenta Science positions in Q1 2022 and 0 closed out, a net change of +1 holder.
- The largest Genenta Science buyer in Q1 2022 was Bank of America, an estimated $3.31K added.
- The largest Genenta Science seller in Q1 2022 was UBS Group, an estimated $1.61K sold.
Based on aggregated 13F filings for Q1 2022.